On Tuesday, Shares of MGM Resorts International (NYSE:MGM), gained 4.83% to $21.47.
MGM Resorts International, employee volunteers build a house from the ground up, and hand over the keys to an elated single mother and her children. Tens of millions of dollars are spent conducting business with minority- and women-owned enterprises, supporting the company’s planned objectives and commitment to diversity. MGM Resorts and NRG Renew partner to install one of the nation’s largest rooftop solar arrays at Mandalay Bay Resort and Casino, stretching a massive 20 acres.
These are just a few of the powerful displays of corporate citizenship chronicled in MGM Resorts’ 2014 Annual Corporate Social Responsibility Report. Themed “Inspiration Starts With Us!”, the report features the company’s accomplishments in corporate social responsibility (CSR), which comprises Diversity and Inclusion, Philanthropy and Community Engagement, and Environmental Sustainability initiatives.
MGM Resorts International, through its auxiliaries, owns and/or operates casino resorts. It operates through two segments, Wholly Owned Domestic Resorts and MGM China. The company’s casino resorts offer gaming, hotel, convention, dining, entertainment, retail, and other resort amenities.
Shares of Infinera Corp. (NASDAQ:INFN), declined -3.92% to $20.57, during its last trading session.
Infinera, declared Nick Walden as senior vice president of sales, EMEA with responsibility for leading Infinera’s sales activities in the Europe, Middle East, and Africa (EMEA) markets.
Mr. Walden comes with 20 years of industry insight and experience gained through a range of leadership positions. Regarded as a highly practiced and collaborative sales and business leader, Mr. Walden has achieved transformational business outcomes with customers across the EMEA telecommunications sector.
Infinera Corporation provides optical transport networking equipment, software, and services for telecommunications service providers, Internet content providers, cable operators, wholesale and enterprise carriers, research and education institutions, and government entities worldwide.
Finally, Cytori Therapeutics Inc (NASDAQ:CYTX), ended its last trade with 6.41% gain, and closed at $0.380.
Cytori Therapeutics declared that Mr. John D. Harris has been designated as Vice President and General Manager of Cell Therapy, a newly created role to be based in Tokyo, Japan. The role will focus on growth and development of the company’s existing and future global cell therapy commercial operations. Mr. Harris’ start date is set for October 1st, 2015.
“Cytori has recruited a very accomplished executive to assist us optimally position our therapeutic platform in the existing market, evaluate future global opportunities and to ensure we are prepared to transition to full commercial launch of our late-stage clinical programs,” said Dr. Marc H. Hedrick, President and CEO of Cytori. “John is uniquely qualified for this role for a number of reasons, counting his demonstrated leadership capabilities, familiarity with the Japanese & Asia-Pacific markets, and his first-hand knowledge of global cell therapy trends and opportunities.”
Mr. Harris joins Cytori from Becton Dickinson, where he serves as President of Becton Dickinson’s Japanese operations, which comprise a production facility, over 550 employees, and about $315 million in revenues.
Cytori Therapeutics, Inc., a biotechnology company, develops cell therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy compriseing of a heterogeneous population of specialized cells, counting stem cells for the treatment of patients with scleroderma hand dysfunction, orthopedic disorders, cardiovascular disease, urinary incontinence, and thermal burns combined with radiation injury.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
